MY ACCOUNT | NEWSLETTER |

Infective endocarditis in dogs


The aim of this study was to determine the causative organisms, clinical features and outcome of canine infective endocarditis in the U.K.

The research team searched medical records of three veterinary referral hospitals for dogs with infective endocarditis between December 2009 to December 2019. They recorded signalment, clinical signs, causative organism, valve affected, treatment and survival data.

The team included 77 cases with possible or definite infective endocarditis, according to the modified Duke criteria. The majority or 40 of 77 were large breeds. The team identified 47 of 77 or 61% male dogs and the mean age was 7.3 ±3 years. 

Researchers identified a causative organism in 26 of 77 or 33.8% cases. The most common organisms were Escherichia coli (25.9%), Pasteurella spp. (18.5%), Staphylococcus spp. (14.8%) and Corynebacterium spp. (14.8%). 

The team did not detect Bartonella spp. in any patient. They found that the mitral valve was affected in 62.3% of the dogs. Clinical features were non-specific, with lethargy being the most common clinical sign observed (68.8%). 

Fifty-three dogs (68.8%) survived to discharge. The median survival time post discharge was 425 days. The development of congestive heart failure was associated with a poorer outcome. Cardiac troponin concentration, antithrombotic use and the development of thromboembolism or arrhythmias were not significantly associated with outcome.

Researchers concluded that some dogs with infective endocarditis that survive to discharge can have a long lifespan. The inability to detect an underlying organism is common and Bartonella spp. may be a less prevalent cause of canine infective endocarditis in the U.K. than in the U.S.

M Berrezaie, et al. “Infective endocarditis in dogs in the UK: 77 cases (2009-2019).” J Small Anim Pract. 2022 Nov 6. doi: 10.1111/jsap.13561.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top